Filing Flows

Filing Flows › Kenvue (KVUE) › Q2 2026 › vs Q2 2025

Kenvue (KVUE) Q2 2026 vs Q2 2025 (year over year)

Kenvue's revenue rose $116M (+3%) from $3.8B in Q2 2025 to $4.0B in Q2 2026. The biggest changes: Skin Health and Beauty +$54.0M (+5%); Self Care +$34.0M (+2%); Essential Health +$28.0M (+2%). Gross margin 58.2% against 58.9% (-0.7 pts).

Kenvue, Q2 2026: revenue $4.0B (+3% year over year), operating margin 17.7%, net earnings $456M, operating cash flow $688M. The chart draws each line against Q2 2025, the increases inside each band.

Kenvue: what changed, Q2 2026 vs Q2 2025Kenvue: what changed, Q2 2026 vs Q2 2025Free cash flow (OCF − capex)$91.0MCost of revenue$76.0MOperating cash flow$67.0MSkin Health and Beauty$54.0MGross profit$40.0MNet earnings$36.0MSelf Care$34.0MOperating expenses$33.0MWorking capital & other$33.0MEssential Health$28.0M

Margins

Q2 2026Q2 2025Change
Gross margin58.2%58.9%-0.7 pts
Operating margin17.7%18.0%-0.4 pts
Net margin11.5%10.9%+0.6 pts
Free cash flow margin15.8%13.9%+1.9 pts

Every line

LineQ2 2026Q2 2025Change%
Self Care$1.6B$1.6B$34.0M+2%
Essential Health$1.3B$1.2B$28.0M+2%
Skin Health and Beauty$1.1B$1.1B$54.0M+5%
Revenue$4.0B$3.8B$116M+3%
Gross profit$2.3B$2.3B$40.0M+2%
Cost of revenue$1.7B$1.6B$76.0M+5%
Operating profit$699M$692M$7.0M+1%
Operating expenses$1.6B$1.6B$33.0M+2%
Pre-tax earnings$598M$588M$10.0M+2%
Other expense, net$101M$104M−$3.0M-3%
Net earnings$456M$420M$36.0M+9%
Income tax$142M$168M−$26.0M-15%
Depreciation & amortization$145M$142M$3.0M+2%
Share-based compensation$32.0M$37.0M−$5.0M-14%
Working capital & other$55.0M$22.0M$33.0M+150%
Operating cash flow$688M$621M$67.0M+11%
Free cash flow (OCF − capex)$624M$533M$91.0M+17%
Capital expenditures$64.0M$88.0M−$24.0M-27%

Questions

How much did Kenvue's revenue grow year over year in Q2 2026?

Kenvue's revenue rose $116M (+3%) from $3.8B in Q2 2025 to $4.0B in Q2 2026.

What drove Kenvue's revenue change in Q2 2026?

Skin Health and Beauty +$54.0M (+5%); Self Care +$34.0M (+2%); Essential Health +$28.0M (+2%).

Q2 2026 results → · Compare in the interactive Sankey →